|
1
|
Rinella ME: Nonalcoholic fatty liver
disease: A systematic review. JAMA. 313:2263–2273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mancuso A and Perricone G: Hepatocellular
Carcinoma and Liver Transplantation: State of the Art. J Clin
Transl Hepatol. 2:176–181. 2014. View Article : Google Scholar
|
|
3
|
Khan FZ, Perumpail RB, Wong RJ and Ahmed
A: Advances in hepatocellular carcinoma: Nonalcoholic
steatohepatitis-related hepatocellular carcinoma. World J Hepatol.
7:2155–2161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
She WH and Chok KS: Strategies to increase
the resectability of hepatocellular carcinoma. World J Hepatol.
7:2147–2154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng X, Franklin DA, Dong J and Zhang Y:
MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res.
74:7161–7167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Watson ME, Diepeveen LA, Stubbs KA and
Yeoh GC: Glycosylation-related diagnostic and therapeutic drug
target markers in hepatocellular carcinoma. J Gastrointestin Liver
Dis. 24:349–357. 2015.PubMed/NCBI
|
|
7
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim ED and Sung S: Long noncoding RNA:
Unveiling hidden layer of gene regulatory networks. Trends Plant
Sci. 17:16–21. 2012. View Article : Google Scholar
|
|
9
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar :
|
|
10
|
Yu TT, Xu XM, Hu Y, Deng JJ, Ge W, Han NN
and Zhang MX: Long noncoding RNAs in hepatitis B virus-related
hepatocellular carcinoma. World J Gastroenterol. 21:7208–7217.
2015.PubMed/NCBI
|
|
11
|
Tu ZQ, Li RJ, Mei JZ and Li XH:
Down-regulation of long non-coding RNA GAS5 is associated with the
prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol.
7:4303–4309. 2014.PubMed/NCBI
|
|
12
|
Zhang X, Rice K, Wang Y, Chen W, Zhong Y,
Nakayama Y, Zhou Y and Klibanski A: Maternally expressed gene 3
(MEG3) noncoding ribonucleic acid: Isoform structure, expression,
and functions. Endocrinology. 151:939–947. 2010. View Article : Google Scholar :
|
|
13
|
Zhuo H, Tang J, Lin Z, Jiang R, Zhang X,
Ji J, Wang P and Sun B: The aberrant expression of MEG3 regulated
by UHRF1 predicts the prognosis of hepatocellular carcinoma. Mol
Carcinog. Epub: Jan 16. 2015.(Epub ahead of print). View Article : Google Scholar
|
|
14
|
Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang
Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein
(HBx)-related long noncoding RNA (lncRNA) down-regulated expression
by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by
targeting the intermediate filament protein vimentin. Hepatology.
57:1882–1892. 2013. View Article : Google Scholar
|
|
15
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar
|
|
17
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long noncoding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan SX, Yang F, Yang Y, Tao QF, Zhang J,
Huang G, Yang Y, Wang RY, Yang S, Huo XS, et al: Long noncoding RNA
associated with microvascular invasion in hepatocellular carcinoma
promotes angiogenesis and serves as a predictor for hepatocellular
carcinoma patients' poor recurrence-free survival after
hepatectomy. Hepatology. 56:2231–2241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu W, Bhagat TD, Yang X, Song JH, Cheng Y,
Agarwal R, Abraham JM, Ibrahim S, Bartenstein M, Hussain Z, et al:
Hypomethylation of noncoding DNA regions and overexpression of the
long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and
esophageal adenocarcinoma. Gastroenterology. 144:956–966.e4. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye Y, Chen J, Zhou Y, Fu Z, Zhou Q, Wang
Y, Gao W, Zheng S, Zhao X, Chen T, et al: High expression of
AFAP1-AS1 is associated with poor survival and short-term
recurrence in pancreatic ductal adenocarcinoma. J Transl Med.
13:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao
Q, Chen P, Shi L, Lian Y, Jing Y, et al: Upregulated long
non-coding RNA AFAP1-AS1 expression is associated with progression
and poor prognosis of nasopharyngeal carcinoma. Oncotarget.
6:20404–20418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X,
Zhang W, Deng H, Zhou M, Peng S, et al: AFAP1-AS1, a long noncoding
RNA upregulated in lung cancer and promotes invasion and
metastasis. Tumour Biol. Aug 6–2015.(Epub ahead of print).
|
|
24
|
Sun J, Bie B, Zhang S, Yang J and Li Z:
Long non-coding RNAs: Critical players in hepatocellular carcinoma.
Int J Mol Sci. 15:20434–20448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iranpour M, Soudyab M, Geranpayeh L,
Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S:
Expression analysis of four long noncoding RNAs in breast cancer.
Tumour Biol. Sep 27–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang Q, Ni Z, Cheng Z, Xu J, Yu H and Yin
P: Three circulating long non-coding RNAs act as biomarkers for
predicting NSCLC. Cell Physiol Biochem. 37:1002–1009. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du
YE, Wen S, Xu L, Tang X, Tang S, et al: LncRNA-Hh strengthen cancer
stem cells generation in twist-positive breast cancer via
activation of Hedgehog signaling pathway. Stem Cells. Sept
29–2015.(Epub ahead of print). PubMed/NCBI
|
|
30
|
Zhang A, Zhao JC, Kim J, Fong KW, Yang YA,
Chakravarti D, Mo YY and Yu J: LncRNA HOTAIR enhances the
androgen-receptor-mediated transcriptional program and drives
castration-resistant prostate cancer. Cell Rep. 13:209–221. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu L, Luo F, Liu Y, Liu X, Shi L, Lu X and
Liu Q: Post-transcriptional silencing of the lncRNA MALAT1 by
miR-217 inhibits the epithelial-mesenchymal transition viaenhancer
of zeste homolog 2 in the malignant transformation of HBE cells
induced by cigarette smoke extract. Toxicol Appl Pharmacol.
289:276–285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie M, Sun M, Zhu YN, Xia R, Liu YW, Ding
J, Ma HW, He XZ, Zhang ZH, Liu ZJ, et al: Long noncoding RNA
HOXA-AS2 promotes gastric cancer proliferation by epigenetically
silencing P21/PLK3/DDTT3 expression. Oncotarget. 6:33587–33601.
2015.PubMed/NCBI
|
|
33
|
Naemura M, Murasaki C, Inoue Y, Okamoto H
and Kotake Y: Long noncoding RNA ANRIL regulates proliferation of
non-small cell lung cancer and cervical cancer cells. Anticancer
Res. 35:5377–5382. 2015.PubMed/NCBI
|
|
34
|
Zhang CL, Zhu KP, Shen GQ and Zhu ZS: A
long non-coding RNA contributes to doxorubicin resistance of
osteosarcoma. Tumour Biol. Sep 25–2015.(Epub ahead of print).
|
|
35
|
Yu OM and Brown JH: G protein-coupled
receptor and RhoA-stimulated transcriptional responses: Links to
inflammation, differentiation, and cell proliferation. Mol
Pharmacol. 88:171–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yin K, Zhao G, Huang X, Gao G, Sun H, Wei
Q, Liu Q, Li M, Xu C, Zhu S, et al: Inhibition of RhoA expression
by adenovirus-mediated siRNA combined with TNF-α induced apoptosis
of hepatocarcinoma cells. Biomed Mater Eng. 26(Suppl 1):
S2055–S2067. 2015.
|
|
37
|
Serizawa N, Tian J, Fukada H, Baghy K,
Scott F, Chen X, Kiss Z, Olson K, Hsu D, Liu FT, et al: Galectin 3
regulates HCC cell invasion by RhoA and MLCK activation. Lab
Invest. 95:1145–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin L, Yang XM, Li J, Zhang YL, Qin W and
Zhang ZG: Microfilament regulatory protein MENA increases activity
of RhoA and promotes metastasis of hepatocellular carcinoma. Exp
Cell Res. 327:113–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong CM, Wei L, Au SL, Fan DN, Zhou Y,
Tsang FH, Law CT, Lee JM, He X, Shi J, et al: MiR-200b/200c/429
subfamily negatively regulates Rho/ROCK signaling pathway to
suppress hepatocellular carcinoma metastasis. Oncotarget.
6:13658–13670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gu DL, Chen YH, Shih JH, Lin CH, Jou YS
and Chen CF: Target genes discovery through copy number alteration
analysis in human hepatocellular carcinoma. World J Gastroenterol.
19:8873–8879. 2013. View Article : Google Scholar :
|
|
41
|
Cleary SP, Jeck WR, Zhao X, Chen K,
Selitsky SR, Savich GL, Tan TX, Wu MC, Getz G, Lawrence MS, et al:
Identification of driver genes in hepatocellular carcinoma by exome
sequencing. Hepatology. 58:1693–1702. 2013. View Article : Google Scholar : PubMed/NCBI
|
